Which NIOSH table covers non-antieoplastic drugs?

Which NIOSH table covers non-antieoplastic drugs?

• A. Table 1
• B. Table 3
• C. Table 2
• D. Table 4

Answer: (B)

Non-antieoplastic drugs are grouped separately in the NIOSH system because their hazards aren’t about being cytotoxic; they arise from other toxicities or risks. Table 3 is the designated resource for these drugs, outlining the containment practices, PPE, and engineering controls needed to protect workers during preparation, administration, and disposal. This separation helps ensure that each category of hazard—cytotoxic (antineoplastic) versus non-antieoplastic—has appropriate, tailored handling requirements. The other tables correspond to different hazard groups and carry different handling guidance, so they aren’t the source for managing non-antieoplastic hazards.

Non-antieoplastic drugs are grouped separately in the NIOSH system because their hazards aren’t about being cytotoxic; they arise from other toxicities or risks. Table 3 is the designated resource for these drugs, outlining the containment practices, PPE, and engineering controls needed to protect workers during preparation, administration, and disposal. This separation helps ensure that each category of hazard—cytotoxic (antineoplastic) versus non-antieoplastic—has appropriate, tailored handling requirements. The other tables correspond to different hazard groups and carry different handling guidance, so they aren’t the source for managing non-antieoplastic hazards.